Medicine & Life Sciences
1,4-cyclohexadiene
28%
Animal Models
10%
Apamin
38%
Ataxia
14%
Autoimmune Experimental Encephalomyelitis
16%
Blood Vessels
8%
Brain Injuries
13%
Calcium Signaling
16%
Calcium-Activated Potassium Channels
18%
Cyclohexenes
31%
Epilepsy
11%
Epithelium
10%
Erythrocytes
10%
Fibroblasts
10%
Infarction
11%
Intermediate-Conductance Calcium-Activated Potassium Channels
100%
Intestinal Mucosa
14%
Lymphocytes
9%
Membrane Potentials
13%
Memory Disorders
14%
Parkinson Disease
11%
Peptides
8%
Phase III Clinical Trials
16%
Schizophrenia
11%
senicapoc
28%
Sickle Cell Anemia
15%
Small-Conductance Calcium-Activated Potassium Channels
93%
Smooth Muscle Myocytes
12%
Structure-Activity Relationship
16%
Subdural Hematoma
17%
Therapeutics
9%
TRAM 34
24%
Transgenic Mice
12%
Vascular Endothelium
15%
Vascular Smooth Muscle
13%
Chemical Compounds
Calcium(0)
14%
Cyclohexadiene
50%
Disorder
15%
Membrane Potential
20%
Molecule
12%
Peptide
10%
Structure-Activity Relationship
15%
TRAM-34
38%
Triarylmethane
84%
Volume
10%